Keywords: Mayne Pharma, Metrics, M&A, Contract development, Niche generics

Mayne Pharma acquires Metrics for upfront $105 million

Article | 09 October 2012

Print This

Australia’s Mayne Pharma (ASX: MYX) has entered into a binding agreement to acquire Metrics, a privately-owned, US-based provider ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in